摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-Benzo[1,3]dioxol-5-ylmethyl-9-butyl-2-fluoro-9H-purin-6-ylamine

中文名称
——
中文别名
——
英文名称
8-Benzo[1,3]dioxol-5-ylmethyl-9-butyl-2-fluoro-9H-purin-6-ylamine
英文别名
8-Benzo[1,3]dioxol-,5-ylmethyl-9-butyl-2-fluoro-9H-purin-6-ylamine;8-(1,3-benzodioxol-5-ylmethyl)-9-butyl-2-fluoropurin-6-amine
8-Benzo[1,3]dioxol-5-ylmethyl-9-butyl-2-fluoro-9H-purin-6-ylamine化学式
CAS
——
化学式
C17H18FN5O2
mdl
——
分子量
343.361
InChiKey
ARWHTQLGMWHTAZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    88.1
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    胡椒乙酸sodium methylate 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 氟化氢吡啶N,N-二异丙基乙胺 作用下, 以 乙醇N,N-二甲基甲酰胺 为溶剂, 反应 38.16h, 生成 8-Benzo[1,3]dioxol-5-ylmethyl-9-butyl-2-fluoro-9H-purin-6-ylamine
    参考文献:
    名称:
    Adenine derived inhibitors of the molecular chaperone HSP90—SAR explained through multiple X-ray structures
    摘要:
    Multiple co-crystal structures of an adenine-based series of inhibitors bound to the molecular chaperone Hsp90 have been determined. These structures explain the observed SAR for previously described compounds and new compounds, which possess up to 8-fold improved potency against the isolated enzyme. Anti-tumour cell potency and mechanism of action data is also described for the most potent compounds. These data should enable the design of more potent Hsp90 inhibitors. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.11.011
点击查看最新优质反应信息

文献信息

  • Advanced drug development and manufacturing
    申请人:Los Alamos National Security, LLC
    公开号:EP2511844A2
    公开(公告)日:2012-10-17
    There is described an apparatus for measuring protein characteristics comprising an X-ray fluorescence (XRF) spectrometer comprising a source of polychromatic X-rays, an X-ray detector, a protein, a molecule that has been exposed to and at least weakly binds to the protein, a plurality of X-ray fluorescence signal data obtained by irradiating chemical elements in the protein and molecule with the polychromatic X-rays and a security system for maintaining records for the data from the plurality of X-ray fluorescence signal measurements. There is also described an x-ray microscope for measuring a sample.
    描述了一种测量蛋白质特性的仪器,该仪器包括一个 X 射线荧光 (XRF) 光谱仪,其中包括一个多色 X 射线源、一个 X 射线探测器、一个蛋白质、一个已暴露于该蛋白质并至少与该蛋白质弱结合的分子、通过用多色 X 射线照射蛋白质和分子中的化学元素而获得的多个 X 射线荧光信号数据,以及一个用于维护多个 X 射线荧光信号测量数据记录的安全系统。此外,还介绍了一种用于测量样品的 X 射线显微镜。
  • X-RAY FLUORESCENCE ANALYSIS METHOD
    申请人:Los Alamos National Security, LLC
    公开号:EP2084519B1
    公开(公告)日:2012-08-01
  • X-ray microscope
    申请人:XRpro Sciences, Inc.
    公开号:EP2511844B1
    公开(公告)日:2015-08-12
  • Advanced Drug Development and Manufacturing
    申请人:XRpro Sciences, Inc.
    公开号:US20150309021A1
    公开(公告)日:2015-10-29
    X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical. For estimating the binding selectivities of a chemical versus chemical analogs, for measuring post translational modification of proteins, and for drug manufacturing.
  • Adenine derived inhibitors of the molecular chaperone HSP90—SAR explained through multiple X-ray structures
    作者:Brian Dymock、Xavier Barril、Mandy Beswick、Adam Collier、Nicholas Davies、Martin Drysdale、Alexandra Fink、Christophe Fromont、Roderick E. Hubbard、Andrew Massey、Allan Surgenor、Lisa Wright
    DOI:10.1016/j.bmcl.2003.11.011
    日期:2004.1
    Multiple co-crystal structures of an adenine-based series of inhibitors bound to the molecular chaperone Hsp90 have been determined. These structures explain the observed SAR for previously described compounds and new compounds, which possess up to 8-fold improved potency against the isolated enzyme. Anti-tumour cell potency and mechanism of action data is also described for the most potent compounds. These data should enable the design of more potent Hsp90 inhibitors. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多